The changing role of glucocorticoids in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis.

Dhaun, Neeraj; McAdoo, Stephen P

Dhaun, Neeraj; McAdoo, Stephen P.

Afiliação

Dhaun N; University/British Heart Foundation Centre of Research Excellence, Centre of Cardiovascular Science, University of Edinburgh, Queen's Medical Research Institute, Edinburgh, UK; Department of Renal Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK. Electronic address: bean.dhaun@ed.ac.uk.
McAdoo SP; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, Hammersmith Hospital Campus, UK; Department of Renal Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, UK. Electronic address: s.mcadoo@imperial.ac.uk.

Kidney Int ; 101(2): 201-204, 2022 02.

Article em En | MEDLINE | ID: mdl-35065686

Assuntos

Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos; Glucocorticoides; Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos/tratamento farmacológico; Ciclofosfamida; Glucocorticoides/uso terapêutico; Humanos; Imunossupressores

Palavras-chave

anti-neutrophil cytoplasm antibody; glucocorticoid; vasculitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos / Glucocorticoides Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Kidney Int Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google